Editas Medicine to Present at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Editas Medicine, a clinical stage genome editing company, will have its President and CEO, Gilmore O’Neill, present at the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023, at 4:30 p.m. PT / 7:30 p.m. ET in San Francisco, CA. The presentation will be accessible via live webcast on the company’s website, with an archived replay available for 30 days post-event. Editas Medicine focuses on developing transformative genomic medicines using CRISPR technology to treat serious diseases globally, holding exclusive licenses for key patents.

CAMBRIDGE, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical stage genome editing company, today announced that the Company’s President and CEO Gilmore O’Neill, M.B., M.M.Sc., will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, 4:30 p.m. PT / 7:30 p.m. ET in San Francisco, CA.

A live webcast of the presentation will be available on the “Investors” section of the Editas Medicine website at www.editasmedicine.com. An archived replay will be available on the website for approximately 30 days following the presentation.

About Editas Medicine
As a clinical stage genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. Editas Medicine is the exclusive licensee of Broad Institute and Harvard University’s Cas9 patent estates and Broad Institute’s Cas12a patent estate for human medicines. For the latest information and scientific presentations, please visit www.editasmedicine.com.

Contacts:
Media
Cristi Barnett
(617) 401-0113
cristi.barnett@editasmed.com

Investors:
Ron Moldaver
(617) 401-9052
ir@editasmed.com

FAQ

What is the date and time of Editas Medicine's presentation at the J.P. Morgan Healthcare Conference?

Editas Medicine will present on January 10, 2023, at 4:30 p.m. PT / 7:30 p.m. ET.

Where can I watch the Editas Medicine presentation live?

The presentation will be available live on Editas Medicine's website in the 'Investors' section.

How long will the archived replay of Editas Medicine's presentation be available?

The archived replay will be available for approximately 30 days following the presentation.

What is the focus of Editas Medicine as a company?

Editas Medicine focuses on developing genome editing treatments using CRISPR technology for serious diseases.

Who is presenting for Editas Medicine at the conference?

Gilmore O’Neill, the President and CEO of Editas Medicine, will be presenting.